OREX

Orexigen Therapeutics, Inc. News Headlines

$6.495
*  
0.115
1.74%
Get OREX Alerts
*Delayed - data as of May 6, 2015  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OREX After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By







Arena: Belviq Television Ads Resume After 1 Week Hiatus
2/24/2015 8:11:00 AM - Seeking Alpha


Orexigen's Contrave Scaling New Heights
2/23/2015 11:01:00 AM - Seeking Alpha


Orexigen: Contrave Scripts Pass 9,000 - Closing In On Qsymia
2/23/2015 11:00:00 AM - Seeking Alpha




Arena's Belviq Slows At A Bad Time
2/23/2015 9:57:00 AM - Seeking Alpha








Orexigen's Contrave Resumes Solid Growth Rate
2/17/2015 8:45:00 AM - Seeking Alpha










Vivus' Qsymia Headed In The Wrong Direction
2/7/2015 5:44:00 AM - Seeking Alpha


Orexigen: Contrave Script Sales Dip. Why?
2/6/2015 6:36:00 PM - Seeking Alpha


Arena Scripts Grow, But Pace Is Slower Than Needed
2/6/2015 6:31:00 PM - Seeking Alpha


Arena's Belviq Keeps Up Momentum During A Flat Week
2/6/2015 4:05:00 PM - Seeking Alpha






Arena Pharmaceuticals' Belviq Set To Surge In 2015
2/2/2015 1:47:00 PM - Seeking Alpha